Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

Software for analysis and reporting of single cell data will advance research into cell function, disease progression, and therapeutic response

SAN DIEGO & ASHLAND, Ore.– Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell next-generation sequencing (NGS) data. Under the agreement FlowJo, LLC, the producer of FlowJo, market-leading software for single cell analysis, will develop a new software application. It will provide additional secondary and tertiary analysis and visualization of datasets with an intuitive approach built on 19 years of experience working with cell biologists and immunologists in single cell phenotyping. The application will seamlessly integrate with Illumina’s Single Cell RNA BaseSpace app, and provide a solution accelerating discovery.

“We are excited to partner with Illumina on this project to bring new tools for analyzing and visualizing NGS data to cell biology,” said Michael Stadnisk

< | >